aluates Reports

$ 0.0

Automative

Global Prostate Cancer Nuclear Medicine Diagnostics Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-39J855

Global Prostate Cancer Nuclear Medicine Diagnostics Market Insights and Forecast to 2028

BUY CHAPTERS

Global Prostate Cancer Nuclear Medicine Diagnostics Market Research Report 2025

Code: QYRE-Auto-39J855

Report

July 2025

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Blue Earth Diagnostics

PETNET Solutions

Cardinal Health

Lantheus Medical Imaging

Jubilant Pharma

NCM-USA

Progenics Pharma

Telix Pharma

ImaginAb

Theragnostics

Novartis

Alliance Medical

Prostate Cancer Nuclear Medicine Diagnostics Market Size

The global market for Prostate Cancer Nuclear Medicine Diagnostics was valued at US$ 868 million in the year 2024 and is projected to reach a revised size of US$ 1739 million by 2031, growing at a CAGR of 10.6% during the forecast period.

Prostate Cancer Nuclear Medicine Diagnostics Market

Nuclear medicine, a type of imaging that uses radioactive materials, is a useful tool to detect and also treat prostate cancer. It is a form of diagnostic imaging that helps radiologists determine the stage of cancer.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Nuclear Medicine Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Nuclear Medicine Diagnostics.

The Prostate Cancer Nuclear Medicine Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Nuclear Medicine Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate Cancer Nuclear Medicine Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Prostate Cancer Nuclear Medicine Diagnostics Market Report

Report Metric	Details
Report Name	Prostate Cancer Nuclear Medicine Diagnostics Market
Accounted market size in year	US$ 868 million
Forecasted market size in 2031	US$ 1739 million
CAGR	10.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	SPECT PET
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Blue Earth Diagnostics, PETNET Solutions, Cardinal Health, Lantheus Medical Imaging, Jubilant Pharma, NCM-USA, Progenics Pharma, Telix Pharma, ImaginAb, Theragnostics, Novartis, Alliance Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Nuclear Medicine Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Prostate Cancer Nuclear Medicine Diagnostics Market growing?

Ans: The Prostate Cancer Nuclear Medicine Diagnostics Market witnessing a CAGR of 10.6% during the forecast period 2025-2031.

What is the Prostate Cancer Nuclear Medicine Diagnostics Market size in 2031?

Ans: The Prostate Cancer Nuclear Medicine Diagnostics Market size in 2031 will be US$ 1739 million.

Who are the main players in the Prostate Cancer Nuclear Medicine Diagnostics Market report?

Ans: The main players in the Prostate Cancer Nuclear Medicine Diagnostics Market are Blue Earth Diagnostics, PETNET Solutions, Cardinal Health, Lantheus Medical Imaging, Jubilant Pharma, NCM-USA, Progenics Pharma, Telix Pharma, ImaginAb, Theragnostics, Novartis, Alliance Medical

What are the Application segmentation covered in the Prostate Cancer Nuclear Medicine Diagnostics Market report?

Ans: The Applications covered in the Prostate Cancer Nuclear Medicine Diagnostics Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Prostate Cancer Nuclear Medicine Diagnostics Market report?

Ans: The Types covered in the Prostate Cancer Nuclear Medicine Diagnostics Market report are SPECT, PET

Recommended Reports

Prostate & Urogenital Cancer

Nuclear Medicine & Imaging

Cancer Diagnostics Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 SPECT

1.2.3 PET

1.3 Market by Application

1.3.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Perspective (2020-2031)

2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Growth Trends by Region

2.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Prostate Cancer Nuclear Medicine Diagnostics Market Dynamics

2.3.1 Prostate Cancer Nuclear Medicine Diagnostics Industry Trends

2.3.2 Prostate Cancer Nuclear Medicine Diagnostics Market Drivers

2.3.3 Prostate Cancer Nuclear Medicine Diagnostics Market Challenges

2.3.4 Prostate Cancer Nuclear Medicine Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Revenue

3.1.1 Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Prostate Cancer Nuclear Medicine Diagnostics Revenue

3.4 Global Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Ratio

3.4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2024

3.5 Global Key Players of Prostate Cancer Nuclear Medicine Diagnostics Head office and Area Served

3.6 Global Key Players of Prostate Cancer Nuclear Medicine Diagnostics, Product and Application

3.7 Global Key Players of Prostate Cancer Nuclear Medicine Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Nuclear Medicine Diagnostics Breakdown Data by Type

4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Type (2026-2031)

5 Prostate Cancer Nuclear Medicine Diagnostics Breakdown Data by Application

5.1 Global Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size (2020-2031)

6.2 North America Prostate Cancer Nuclear Medicine Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025)

6.4 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size (2020-2031)

7.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025)

7.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size (2020-2031)

9.2 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Blue Earth Diagnostics

11.1.1 Blue Earth Diagnostics Company Details

11.1.2 Blue Earth Diagnostics Business Overview

11.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Introduction

11.1.4 Blue Earth Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

11.1.5 Blue Earth Diagnostics Recent Development

11.2 PETNET Solutions

11.2.1 PETNET Solutions Company Details

11.2.2 PETNET Solutions Business Overview

11.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Introduction

11.2.4 PETNET Solutions Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

11.2.5 PETNET Solutions Recent Development

11.3 Cardinal Health

11.3.1 Cardinal Health Company Details

11.3.2 Cardinal Health Business Overview

11.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Introduction

11.3.4 Cardinal Health Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

11.3.5 Cardinal Health Recent Development

11.4 Lantheus Medical Imaging

11.4.1 Lantheus Medical Imaging Company Details

11.4.2 Lantheus Medical Imaging Business Overview

11.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Introduction

11.4.4 Lantheus Medical Imaging Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

11.4.5 Lantheus Medical Imaging Recent Development

11.5 Jubilant Pharma

11.5.1 Jubilant Pharma Company Details

11.5.2 Jubilant Pharma Business Overview

11.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction

11.5.4 Jubilant Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

11.5.5 Jubilant Pharma Recent Development

11.6 NCM-USA

11.6.1 NCM-USA Company Details

11.6.2 NCM-USA Business Overview

11.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Introduction

11.6.4 NCM-USA Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

11.6.5 NCM-USA Recent Development

11.7 Progenics Pharma

11.7.1 Progenics Pharma Company Details

11.7.2 Progenics Pharma Business Overview

11.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction

11.7.4 Progenics Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

11.7.5 Progenics Pharma Recent Development

11.8 Telix Pharma

11.8.1 Telix Pharma Company Details

11.8.2 Telix Pharma Business Overview

11.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction

11.8.4 Telix Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

11.8.5 Telix Pharma Recent Development

11.9 ImaginAb

11.9.1 ImaginAb Company Details

11.9.2 ImaginAb Business Overview

11.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Introduction

11.9.4 ImaginAb Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

11.9.5 ImaginAb Recent Development

11.10 Theragnostics

11.10.1 Theragnostics Company Details

11.10.2 Theragnostics Business Overview

11.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Introduction

11.10.4 Theragnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

11.10.5 Theragnostics Recent Development

11.11 Novartis

11.11.1 Novartis Company Details

11.11.2 Novartis Business Overview

11.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Introduction

11.11.4 Novartis Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

11.11.5 Novartis Recent Development

11.12 Alliance Medical

11.12.1 Alliance Medical Company Details

11.12.2 Alliance Medical Business Overview

11.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Introduction

11.12.4 Alliance Medical Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

11.12.5 Alliance Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Blue Earth Diagnostics

PETNET Solutions

Cardinal Health

Lantheus Medical Imaging

Jubilant Pharma

NCM-USA

Progenics Pharma

Telix Pharma

ImaginAb

Theragnostics

Novartis

Alliance Medical

List of Tables

Table 1. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of SPECT

Table 3. Key Players of PET

Table 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region (2020-2025)

Table 8. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region (2026-2031)

Table 10. Prostate Cancer Nuclear Medicine Diagnostics Market Trends

Table 11. Prostate Cancer Nuclear Medicine Diagnostics Market Drivers

Table 12. Prostate Cancer Nuclear Medicine Diagnostics Market Challenges

Table 13. Prostate Cancer Nuclear Medicine Diagnostics Market Restraints

Table 14. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Players (2020-2025)

Table 16. Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2024)

Table 17. Ranking of Global Top Prostate Cancer Nuclear Medicine Diagnostics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Prostate Cancer Nuclear Medicine Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Prostate Cancer Nuclear Medicine Diagnostics, Headquarters and Area Served

Table 20. Global Key Players of Prostate Cancer Nuclear Medicine Diagnostics, Product and Application

Table 21. Global Key Players of Prostate Cancer Nuclear Medicine Diagnostics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Type (2020-2025)

Table 25. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Type (2026-2031)

Table 27. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Application (2020-2025)

Table 29. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Application (2026-2031)

Table 31. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Blue Earth Diagnostics Company Details

Table 47. Blue Earth Diagnostics Business Overview

Table 48. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product

Table 49. Blue Earth Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025) & (US$ Million)

Table 50. Blue Earth Diagnostics Recent Development

Table 51. PETNET Solutions Company Details

Table 52. PETNET Solutions Business Overview

Table 53. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product

Table 54. PETNET Solutions Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025) & (US$ Million)

Table 55. PETNET Solutions Recent Development

Table 56. Cardinal Health Company Details

Table 57. Cardinal Health Business Overview

Table 58. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product

Table 59. Cardinal Health Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025) & (US$ Million)

Table 60. Cardinal Health Recent Development

Table 61. Lantheus Medical Imaging Company Details

Table 62. Lantheus Medical Imaging Business Overview

Table 63. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product

Table 64. Lantheus Medical Imaging Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025) & (US$ Million)

Table 65. Lantheus Medical Imaging Recent Development

Table 66. Jubilant Pharma Company Details

Table 67. Jubilant Pharma Business Overview

Table 68. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product

Table 69. Jubilant Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025) & (US$ Million)

Table 70. Jubilant Pharma Recent Development

Table 71. NCM-USA Company Details

Table 72. NCM-USA Business Overview

Table 73. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product

Table 74. NCM-USA Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025) & (US$ Million)

Table 75. NCM-USA Recent Development

Table 76. Progenics Pharma Company Details

Table 77. Progenics Pharma Business Overview

Table 78. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product

Table 79. Progenics Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025) & (US$ Million)

Table 80. Progenics Pharma Recent Development

Table 81. Telix Pharma Company Details

Table 82. Telix Pharma Business Overview

Table 83. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product

Table 84. Telix Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025) & (US$ Million)

Table 85. Telix Pharma Recent Development

Table 86. ImaginAb Company Details

Table 87. ImaginAb Business Overview

Table 88. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product

Table 89. ImaginAb Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025) & (US$ Million)

Table 90. ImaginAb Recent Development

Table 91. Theragnostics Company Details

Table 92. Theragnostics Business Overview

Table 93. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product

Table 94. Theragnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025) & (US$ Million)

Table 95. Theragnostics Recent Development

Table 96. Novartis Company Details

Table 97. Novartis Business Overview

Table 98. Novartis Prostate Cancer Nuclear Medicine Diagnostics Product

Table 99. Novartis Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025) & (US$ Million)

Table 100. Novartis Recent Development

Table 101. Alliance Medical Company Details

Table 102. Alliance Medical Business Overview

Table 103. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product

Table 104. Alliance Medical Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025) & (US$ Million)

Table 105. Alliance Medical Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Prostate Cancer Nuclear Medicine Diagnostics Picture

Figure 2. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. SPECT Features

Figure 5. PET Features

Figure 6. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Prostate Cancer Nuclear Medicine Diagnostics Report Years Considered

Figure 12. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region: 2024 VS 2031

Figure 15. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Players in 2024

Figure 16. Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2024

Figure 18. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Country (2020-2031)

Figure 20. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Share by Country (2020-2031)

Figure 24. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region (2020-2031)

Figure 32. China Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Country (2020-2031)

Figure 40. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Share by Country (2020-2031)

Figure 44. Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Blue Earth Diagnostics Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

Figure 48. PETNET Solutions Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

Figure 49. Cardinal Health Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

Figure 50. Lantheus Medical Imaging Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

Figure 51. Jubilant Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

Figure 52. NCM-USA Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

Figure 53. Progenics Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

Figure 54. Telix Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

Figure 55. ImaginAb Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

Figure 56. Theragnostics Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

Figure 57. Novartis Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

Figure 58. Alliance Medical Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Nuclear Medicine Radioisotopes Market Insights Forecast to 2030

Global Radioisotopes in Medicine Market Research Report 2025

Global Nuclear Medicine Camera Market Research Report 2024

Global Prostate Cancer Medicine Market Insights Forecast to 2030

Global Nuclear Medicine Imaging System Market Research Report 2024

Nuclear Medicine Science Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nuclear Medicine Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Radioactive Therapeutic Drugs Market Research Report 2024

Nuclear Medicine Diagnostic Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Research Report 2024

Nuclear Medicine Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030

Global Nuclear Medicine Market Research Report 2025

Global Medical Radioisotopes Market Research Report 2025

Global Therapeutic Radioisotopes Market Insights Forecast to 2030

Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030

Global Nuclear Imaging Service Market Research Report 2024

Global Nuclear Medicine Solutions Market Research Report 2024

Global Nuclear Radiopharmaceutical Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions